TECHWIRE 30
(CIX: WRAL30)  916.83  down arrow-1.85  (-0.2 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: Apple)  443.54  up arrow+1.4  (0.32 %)  Updated: 01:09 PM EDT, May 24 2013
(NY: Quintiles)  45.09  up arrow+0.09  (0.2 %)  Updated: 01:04 PM EDT, May 24 2013
(OP: BASF SE)  94.72  down arrow-1.43  (-1.49 %)  Updated: 12:56 PM EDT, May 24 2013
(NQ: BioCryst)  1.60  down arrow-0.06  (-3.61 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: BioDelivery)  4.49  down arrow-0.02  (-0.33 %)  Updated: 01:07 PM EDT, May 24 2013
(NQ: CEMP)  6.90  up arrow+0.02  (0.29 %)  Updated: 01:01 PM EDT, May 24 2013
(NQ: Cisco Systems)  23.59  up arrow+0.08  (0.34 %)  Updated: 01:09 PM EDT, May 24 2013
(NQ: Cornerstone)  8.33  down arrow-0.09  (-1.01 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: Cree)  59.42  down arrow-1.26  (-2.08 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: DARA)  0.73  down arrow-0.02  (-2.51 %)  Updated: 01:05 PM EDT, May 24 2013
(NY: EMC Corp.)  23.65  down arrow-0.01  (-0.06 %)  Updated: 01:09 PM EDT, May 24 2013
(NQ: Extreme Networks)  3.49  up arrow+0.07  (1.9 %)  Updated: 01:07 PM EDT, May 24 2013
(NQ: Facebook)  24.57  down arrow-0.5  (-1.98 %)  Updated: 01:09 PM EDT, May 24 2013
(NY: GlaxoSmithKline)  52.87  up arrow+0.14  (0.27 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: Google)  873.79  down arrow-9  (-1.02 %)  Updated: 01:08 PM EDT, May 24 2013
(NY: IBM)  205.84  down arrow-0.32  (-0.16 %)  Updated: 01:09 PM EDT, May 24 2013
(NY: LH)  99.98  down arrow-0.73  (-0.72 %)  Updated: 01:08 PM EDT, May 24 2013
(OP: Lenovo Group)  19.88  up arrow+0.6  (3.11 %)  Updated: 01:02 PM EDT, May 24 2013
(NY: MRK)  46.81  down arrow-0.52  (-1.1 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: Microsoft Corp)  34.21  up arrow+0.06  (0.16 %)  Updated: 01:09 PM EDT, May 24 2013
(NQ: NetApp)  36.40  down arrow-0.49  (-1.33 %)  Updated: 01:09 PM EDT, May 24 2013
(NY: Novartis AG ADS)  74.05  up arrow+0.23  (0.31 %)  Updated: 01:08 PM EDT, May 24 2013
(OP: Novozymes A/S)  35.18  up arrow+0.08  (0.23 %)  Updated: 01:06 PM EDT, May 24 2013
(NY: Pfizer)  29.03  down arrow-0.08  (-0.27 %)  Updated: 01:09 PM EDT, May 24 2013
(NQ: Pozen)  5.00  up arrow+0.07  (1.42 %)  Updated: 12:55 PM EDT, May 24 2013
(NY: Red Hat)  48.58  down arrow-0.78  (-1.58 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: BBRY)  14.41  down arrow-0.02  (-0.14 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: Salix)  60.40  up arrow+0.71  (1.19 %)  Updated: 01:08 PM EDT, May 24 2013
(NQ: SQI)  23.79  up arrow+0.42  (1.82 %)  Updated: 01:01 PM EDT, May 24 2013

Posts tagged “NCBIO”

February 11

Premium Lock LabCorp to lead Venture Day at CED Life Science conference

LabCorp, the global lab testing firm based in Burlington, and its Chief Executive Officer David King are the host for "Venture Day" at the CED's annual life science conference.

CED Life Science conference CED Life Science conference

January 3

Premium Lock Nobel Prize winner headlines CED Life Science Conference program

Dr. Jack Szostak, a 2009 Nobel Prize winner and a professor of genetics at Harvard, headlines the program for the 22nd CED Life Science Conference next month.

CED Life Science Conference CED Life Science Conference

June 14, 2012

Premium Lock N.C. biotech sector to have big 'footprint' at BIO event

The N.C. Biotechnology Center and other representatives for the state's biotech industry will have a new 3,000 square foot pavillion at the BIO International Convention.

North Carolina's new 3,000 square foot pavilion North Carolina's new 3,000 square foot pavilion

Updated December 22, 2011

Premium Lock Opinion: New life sciences cluster report presents skewed view of RTP's activities

RTP The Triangle is outstanding for life sciences whether reports on U.S. markets score it first, last or in the middle.

October 4, 2010

Premium Lock Sanofi-Aventis launches Genzyme takeover battle

Genzyme France’s Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover attempt for Genzyme Corp., escalating the battle after the U.S. biotech company’s management twice rejected its offer.

Tags: NCBIO
February 21, 2010

Premium Lock CED’s 19th annual Biotech Conference opens Monday in Raleigh

CED Biotech Conference One-on-one partnership meetings are among the event’s highlights. Former Embrex executive will receive top life science honor.

Updated November 16, 2009

Premium Lock Addrenex being bought by Sciele

Addrenex The Atlanta-based buyer will pay about $29 million for developmental drugs it didn't already own.

Updated May 11, 2009

Premium Lock CED’s Medtech conference to highlight emerging medical device industry in N.C.

CED to showcase Medtech In a state where biotech dominates life science headlines, device company execs and CED band together to raise the industry profile. They also want other companies to become more aware of N.C.’s advantages as a home for emerging ventures.

Updated April 17, 2009

Premium Lock ‘We Work for Health’ – New group seeks to spark medical innovation in N.C.

Sam Taylor Biotech, pharmaceutical and medical science firms across the state form ‘one of the biggest life science engines in the country,’ NCBIO executive tells group at kickoff event. He cautions against changes that would ‘undermine’ that engine.

Tags: NCBIO, GSK
Updated March 18, 2009

Premium Lock Biotech Center provides $2.5M to launch medical device center

 Advanced Medical Technology Center for Innovation is set to launch in May. NCBIO led research effort for project. Search for director is under way.

Updated March 16, 2009

Premium Lock Want more jobs? Governor could spark wave of new ventures with a 'Founder’s Credit'

 Governor plans "Founder's Credit" Gov. Bev Perdue sends a lightning bolt through ranks of investors, entrepreneurs with word she will include tax breaks for startups in her budget.

Tags: NCBIO, CED, NCTA
Updated March 16, 2009

Premium Lock Perdue’s ‘Founder’s Credit’ could spark entrepreneurs, investors to launch new businesses

 Entrepreneurs, investors and three of state’s top business organizations express support for N.C. governor’s proposal to ‘exclude’ investments in certain startup companies from capital gains. Current law ‘encourages most successful entrepreneurs to leave the state when they have an exit from their company,’ says one serial entrepreneur.

Updated March 13, 2009

Premium Lock Perdue's 'Founder's Credit' could spark entrepreneurs, investors

'Founder's Credit' is part of governor's budget plan Entrepreneurs, investors and three of state’s top business organizations express support for N.C. governor’s proposal to ‘exclude’ investments in certain startup companies from capital gains. Current law ‘encourages most successful entrepreneurs to leave the state when they have an exit from their company,’ says one serial entrepreneur.

April 14, 2008

Premium Lock N.C. Biotech Training Group Changes Name

NCBIOIMPACT NCBIOIMPACT is new name for consortium involved in biotech worker training programs.

January 8, 2008

Premium Lock NCBIO-Led Group Receives $100,000 Grant for Emerging Technology Effort

NCBIO N.C. Biotech Center funds initial planning for a Center of Innovation focused on medical devices, technology. Grant could lead to additional $2.5M in funding.

Updated October 22, 2007

Premium Lock Various Health Groups Ask Congress to Restore SBIR Grants for Venture-Backed Firms; NC BIO Adds Support

BIO logo Update: Legislation passed in House would restore eligibility of startups to pursue government funding. NC BIO, meanwhile, says it also backs bill.

June 14, 2007

Premium Lock Angel Investment Tax Credit Helps Produce $1.72B in Deals Since 1999

 NCBIO, N.C. Entrepreneurial Association seek renewal of state tax credit for angel investors, citing figures that show $48M in tax credits have generated $274M in direct investments and another $1.45 in additional financing.

May 3, 2007

Premium Lock CED Announces Biotech 2007 Lineup

CED The Council for Entrepreneurial Development on Thursday confirmed the lineup for the eight panel sessions at Biotech 2007.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Jim Roberts
Entrepreneurship
Frank Vinluan
Life science
Scroll

Videos

 
  • Allscripts bringing hundreds of jobs…

  • Nonprofit to handle NC economic…

  • Raleigh goes green, saves green with…

  • Gov. Pat McCrory speaks to NC Chamber

  • NC business leaders unveil job growth…

  • Investment expert: Leading is key in…

  • Retailers tout deals on Twitter

  • Vision for RTP: Social centerpiece